-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CSpb0nv35msE6iz/pIWLuCVFUrnQ9gEjmjZois/1+9w2NkM3UxzFY87+/gAXDapL R6mV6Qf8Ar7dUzSvceTfdA== 0001209191-04-055891.txt : 20041203 0001209191-04-055891.hdr.sgml : 20041203 20041203162243 ACCESSION NUMBER: 0001209191-04-055891 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041119 FILED AS OF DATE: 20041203 DATE AS OF CHANGE: 20041203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AMPER LINDA E CENTRAL INDEX KEY: 0001220024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 041184061 MAIL ADDRESS: STREET 1: C/O OSI PHARMACEUTICALS INC STREET 2: 58 S SERVICE RD CITY: MELVILLE STATE: NY ZIP: 11747 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2004-11-19 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001220024 AMPER LINDA E C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 0 1 0 0 VP Bus. Administration & HR Common Stock 2004-11-19 4 A 0 10 58.16 A 10 D Common Stock 2004-12-01 4 M 0 61 21.55 D 71 D Common Stock 2004-12-01 4 S 0 1 47.95 D 70 D Common Stock 2004-12-01 4 S 0 5 47.97 D 65 D Common Stock 2004-12-01 4 S 0 3 47.98 D 62 D Common Stock 2004-12-01 4 S 0 2 47.99 D 60 D Common Stock 2004-12-01 4 S 0 3 48.00 D 57 D Common Stock 2004-12-01 4 S 0 4 48.01 D 53 D Common Stock 2004-12-01 4 S 0 3 48.02 D 50 D Common Stock 2004-12-01 4 S 0 1 48.03 D 49 D Common Stock 2004-12-01 4 S 0 3 48.29 D 46 D Common Stock 2004-12-01 4 S 0 6 48.37 D 40 D Common Stock 2004-12-01 4 S 0 3 48.40 D 37 D Common Stock 2004-12-01 4 S 0 1 48.41 D 36 D Common Stock 2004-12-01 4 S 0 1 48.45 D 35 D Common Stock 2004-12-01 4 S 0 8 48.50 D 27 D Common Stock 2004-12-01 4 S 0 3 48.57 D 24 D Common Stock 2004-12-01 4 S 0 2 48.58 D 22 D Common Stock 2004-12-01 4 S 0 2 48.60 D 20 D Common Stock 2004-12-01 4 S 0 1 48.64 D 19 D Common Stock 2004-12-01 4 S 0 6 48.65 D 13 D Common Stock 2004-12-01 4 S 0 2 48.66 D 11 D Common Stock 2004-12-01 4 S 0 1 48.74 D 10 D Stock Option (Right to Buy) 21.55 2004-12-01 4 M 0 61 0.00 D 2003-06-12 2012-06-11 Common Stock 61 3200 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months. The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date. Robert L. Van Nostrand by Power of Attorney 2004-12-03 -----END PRIVACY-ENHANCED MESSAGE-----